Genomic Testing Cooperative
GTC offers advanced genomic profiling of DNA/RNA for hematologic cancers globally. We have a fast TAT of 7-10 days and a QNS rate of <1%. Testing can be performed on peripheral blood or bone marrow.
Our cooperative model allows us to partner with laboratories, hospitals, oncology practices and medical professionals to share resources which create efficiencies in cost, turnaround time and quality. GTC’s testing is covered by Medicare, most insurances and is NY state approved.
Our RNA sequencing includes fusion detection, gene expression alternative splicing and prediction.